Literature DB >> 24827961

Antegrade balloon valvuloplasty for critical aortic stenosis in a premature neonate weighing 1100 g.

Alper Akın1, Hayrettin Hakan Aykan, Tevfik Karagöz.   

Abstract

Experiences with invasive cardiac catheterization in low birth weight infants are few. In our clinic, we performed balloon aortic valvuloplasty by antegrade approach in a neonate weighing 1100 g with critical aortic stenosis, patent ductus arteriosus and atrial septal defect. The right femoral vein was accessed with a 4 Fr sheath, and a catheter was placed into the left ventricle from the atrial septal defect along the guidewire for coronary catheter. The aortic valve was passed with guidewire, and the guidewire was placed into the right arteria carotis. After proper placement, the balloon was inflated at 6 atm using an indeflator device until indentation disappeared. After the procedure, the mean pressure gradient over the stenotic aortic valve was measured as 18 mmHg, mild-moderate aortic insufficiency was noticed, and left ventricle contraction was better. To the best of our knowledge, this is the lowest weight infant in the literature to undergo successful antegrade balloon aortic valvuloplasty.

Entities:  

Mesh:

Year:  2014        PMID: 24827961

Source DB:  PubMed          Journal:  Turk J Pediatr        ISSN: 0041-4301            Impact factor:   0.552


  3 in total

1.  Simultaneous balloon aortic valvotomy and patent ductus arteriosus device closure in preterm newborn.

Authors:  Anil Kumar Singhi; Dhritabrata Das; Ashok Mittal
Journal:  J Cardiol Cases       Date:  2021-09-05

2.  Micro-transesophageal Echocardiography Guided Mitral Valve Repair After Balloon Dilation for Aortic Valve Stenosis in a Small Infant.

Authors:  Xiao-Jing Ma; Guo-Ying Huang; Jing Zhang
Journal:  Chin Med J (Engl)       Date:  2015-05-05       Impact factor: 2.628

3.  The results of interventional catheterization in infants weighing under 2,000 g.

Authors:  Birgül Varan; N Kürşad Tokel; Kahraman Yakut; İlkay Erdoğan; Murat Özkan
Journal:  Turk Gogus Kalp Damar Cerrahisi Derg       Date:  2019-06-21       Impact factor: 0.332

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.